Search Results - "KAMIMURA, Mari"

A Comparison of Indocyanine Green Fluorescence Imaging Plus Blue Dye and Blue Dye Alone for Sentinel Node Navigation Surgery in Breast Cancer Patients by Hirano, Akira, Kamimura, Mari, Ogura, Kaoru, Kim, Naomi, Hattori, Akinori, Setoguchi, Yumika, Okubo, Fumie, Inoue, Hiroaki, Miyamoto, Reiko, Kinoshita, Jun, Fujibayashi, Mariko, Shimizu, Tadao

“…Purpose To evaluate two methods of sentinel node navigation surgery (SNNS) using blue dye with and without indocyanine green (ICG) fluorescence imaging (FI) to…”
Get full text

Effect of adjuvant chemotherapy in patients with ER + /HER2− breast cancer, assessed by propensity score matching: significance of nuclear grade and nodal status by Tanaka, Natsuko, Hirano, Akira, Hattori, Akinori, Ogura, Kaoru, Kamimura, Mari, Inoue, Hiroaki, Yukawa, Hiroko, Sakaguchi, Shiho, Matsuoka, Aya, Kodera, Asaka, Shimizu, Tadao

“…Background Survival benefits of chemotherapy (CT) differ among patients with estrogen receptor-positive (ER +) breast cancer. This study investigated the…”
Get full text

Adjuvant Capecitabine for Residual Disease after Standard Neoadjuvant Chemotherapy Among Patients with Triple-Negative Breast Cancer by Ishibashi, Yuko, Hirano, Akira, Yukawa, Hiroko, Kitano, Aya, Kodera, Asaka, Fujita, Saki, Hattori, Akinori, Kamimura, Mari, Shiozawa, Shunichi

“…CREATE-X trial demonstrated the effectiveness of additional capecitabine therapy in prolonging disease-free survival among patients who are HER2 negative,…”
Get more information

Ethinyl Estradiol Therapy for Postmenopausal Women with Heavily Pre-Treated Endocrine-Responsive Metastatic Breast Cancer by Yukawa, Hiroko, Inoue, Hiroaki, Ogura, Kaoru, Sakaguchi, Shiho, Tanaka, Natsuko, Matsuoka, Aya, Kamimura, Mari, Hattori, Akinori, Kodera, Asaka, Naritaka, Yoshihiko, Hirano, Akira

“…Ethinyl estradiol(EE2)therapy has been reported to be an effective endocrine therapy for postmenopausal hormone receptor-positive advanced breast cancer,…”
Get more information

HER2-Positive Breast Cancer with Severe Infusion Reaction to Pertuzumab plus Trastuzumab-A Case Report by Matsuoka, Aya, Inoue, Hiroaki, Ogura, Kaoru, Hattori, Akinori, Yukawa, Hiroko, Sakaguchi, Shiho, Tanaka, Natsuko, Kodera, Asaka, Kamimura, Mari, Naritaka, Yoshihiko, Hirano, Akira

“…A 64-year-old woman detected a tumor in her left breast in July 2015, and the tumor became exposed and ulcerated in January 2016. Subsequently, the tumor began…”
Get more information

Recurrence after sentinel lymph node biopsy with or without axillary lymph node dissection in patients with breast cancer by Takei, Hiroyuki, Suemasu, Kimito, Kurosumi, Masafumi, Horii, Yoshio, Yoshida, Takashi, Ninomiya, Jun, Yoshida, Miho, Hagiwara, Yasutaka, Kamimura, Mari, Hayashi, Yuji, Inoue, Kenichi, Tabei, Toshio

“…A regional nodal recurrence is a major concern after a sentinel lymph node biopsy (SLNB) alone in patients with breast cancer. In this study we investigated…”
Get full text

Epirubicin and Cyclophosphamide Followed by Docetaxel as Primary Systemic Chemotherapy in Locally Advanced Breast Cancer by HIRANO, Akira, SHIMIZU, Tadao, WATANABE, Osamu, KINOSHITA, Jun, KIMURA, Kiyomi, KAMIMURA, Mari, DOMOTO, Kaoru, AIBA, Motohiko, OGAWA, Kenji

“…Background: The aim of this study was to evaluate the activity and toxicity of epirubicin and cyclophosphamide (EC) followed by docetaxel as primary systemic…”
Get full text

Ethinylestradiol Following Everolimus plus Exemestane Was Effective in Postmenopausal Endocrine-Responsive Metastatic Breast Cancer - A Case Report by Matsuoka, Aya, Hirano, Akira, Hattori, Akinori, Ogura, Kaoru, Inoue, Hiroaki, Yukawa, Hiroko, Sakaguchi, Shiho, Tanaka, Natsuko, Kodera, Asaka, Kamimura, Mari, Naritaka, Yoshihiko, Shimizu, Tadao

“…A 71-year-old woman diagnosed with left breast cancer underwent mastectomy and axillary dissection in 1987. Pathological findings showed invasive ductal…”
Get more information

Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective by Takei, Hiroyuki, Kurosumi, Masafumi, Yoshida, Takashi, Ninomiya, Jun, Hagiwara, Yasutaka, Kamimura, Mari, Hayashi, Yuji, Tozuka, Katsunori, Suemasu, Kimito, Inoue, Kenichi, Tabei, Toshio

“…Sentinel lymph node biopsy (SLNB) is standard care for patients with early-stage breast cancer, and axillary lymph node dissection (ALND) is considered…”
Get full text

Added value of the presence of blue nodes or hot nodes in sentinel lymph node biopsy of breast cancer by Takei, Hiroyuki, Suemasu, Kimito, Kurosumi, Masafumi, Horii, Yoshio, Ninomiya, Jun, Kamimura, Mari, Naganuma, Rin, Uchida, Kazuhiro, Igarashi, Kiyomi, Inoue, Kenichi, Tabei, Toshio

“…Combined use of blue dye and radiocolloid is considered to be useful for sentinel lymph node (SLN) biopsy of breast cancer. Whether both techniques together is…”
Get full text

The Combination of Epirubicin plus Docetaxel as Neoadjuvant Chemotherapy in Locally-advanced Breast Cancer by HIRANO, Akira, SHIMIZU, Tadao, OGAWA, Kenji, IMAMURA, Hiroshi, WATANABE, Osamu, KINOSHITA, Jun, OKABE, Toshihiro, KIMURA, Kiyomi, KAMIMURA, Mari, DOMOTO, Kaoru, AIBA, Motohiko

“…Background: The purpose of this study was to evaluate the activity and toxicity of epirubicin plus docetaxel as neoadjuvant chemotherapy for locally advanced…”
Get full text

Clinicopathological characteristics of familial breast cancer by Kamimura, Mari, Takei, Hiroyuki, Suemasu, Kimito

Get more information

Breast-conserving surgery without radiation in elderly women with early breast cancer by Inoue, Hiroaki, Hirano, Akira, Ogura, Kaoru, Kamimura, Mari, Hattori, Akinori, Yukawa, Hiroko, Sakaguchi, Shiho, Tanaka, Natsuko, Matsuoka, Aya, Kodera, Asaka, Shimizu, Tadao

“…Irradiation after breast-conserving surgery (BCS) decreases the incidence of ipsilateral breast tumor recurrence (IBTR) and breast cancer-related death…”
Get full text

Changes in bone mineral density during 5 years of adjuvant exemestane therapy in postmenopausal women with early breast cancer by Hirano, Akira, Inoue, Hiroaki, Ogura, Kaoru, Hattori, Akinori, Yukawa, Hiroko, Sakaguchi, Shiho, Matsuoka, Aya, Kamimura, Mari, Kinoshita, Jun, Naritaka, Yoshihiko, Shimizu, Tadao

“…Abstract only…”
Get full text

Abstract OT2-2-07: A phase II study of S-1 (14 days' administration followed by 7 days' rest) for metastatic breast cancer by Hirano, Akira, Hattori, Akinori, Ogura, Kaoru, Inoue, Hiroaki, Okubo, Fumie, Kamimura, Mari, Sakaguchi, Shiho, Kinoshita, Jun, Miyamoto, Reiko, Jibiki, Norie, Naritaka, Yoshihiko, Shimizu, Tadao

“…Abstract Background S-1, an orally administered fluorinated pyrimidine (FP), improves overall survival in the adjuvant setting of gastric and pancreatic…”
Get full text

The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer by Inoue, Hiroaki, Hirano, Akira, Ogura, Kaoru, Hattori, Akinori, Kamimura, Mari, Okubo, Fumie, Kinoshita, Jun, Kimura, Kiyomi, Shimizu, Tadao

“…Abstract only e11604 Background: Adjuvant therapy with aromatase inhibitors (AI) is associated with increased bone loss in postmenopausal women. We assessed…”
Get full text

Epirubicin/cyclophosphamide followed by docetaxel as the primary systemic therapy for locally advanced breast cancer: The final analysis of a phase II study by Hirano, Akira, Kamimura, Mari, Ogura, Kaoru, Hattori, Akinori, Okubo, Fumie, Inoue, Hiroaki, Kinoshita, Jun, Fujibayashi, Mariko, Shimizu, Tadao

“…Abstract only e12026 Background: The aim of this study was to evaluate the efficacy and safety of epirubicin/cyclophosphamide (EC) followed by docetaxel as the…”
Get full text

The effect of anastrozole on bone mineral density during the first 5 years of adjuvant treatment in postmenopausal women with early breast cancer by Inoue, Hiroaki, Hirano, Akira, Ogura, Kaoru, Hattori, Akinori, Kamimura, Mari, Okubo, Fumie, Tagawa, Hiroko, Sakaguchi, Shiho, Kinoshita, Jun, Shimizu, Tadao

“…Purpose The administration of aromatase inhibitors is associated with bone loss in postmenopausal women. We assessed changes in bone mineral density (BMD) from…”
Get full text

Long‐term effect of exemestane therapy on bone mineral density supported by bisphosphonates: Results of 5‐year adjuvant treatment in postmenopausal women with early‐stage breast cancer by Hirano, Akira, Inoue, Hiroaki, Ogura, Kaoru, Hattori, Akinori, Yukawa, Hiroko, Sakaguchi, Shiho, Matsuoka, Aya, Tanaka, Natsuko, Kodera, Asaka, Kamimura, Mari, Naritaka, Yoshihiko, Shimizu, Tadao

“…Purpose Unlike anastrozole, the effect of long‐term exemestane (EXE) therapy on bone mineral density (BMD) is still unknown. We assessed changes in BMD from…”
Get full text

A Phase II Study of Epirubicin and Cyclophosphamide Followed by Weekly Paclitaxel with or without Trastuzumab as Primary Systemic Therapy in Locally Advanced Breast Cancer by SHIMIZU, Tadao, HIRANO, Akira, KAMIMURA, Mari, OGURA, Kaoru, SKIM, Naomi, WATANABE, Osamu, KINOSHITA, Jun, KIMURA, Kiyomi, OGAWA, Kenji, FUJIBAYASHI, Mariko

“…The aim of this study was to evaluate the activity and toxicity of epirubicin and cyclophosphamide followed by weekly paclitaxel with or without trastuzumab as…”
Get full text